Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation and Depletion: 2018-2024

Historic Depreciation and Depletion for ADC Therapeutics (ADCT) over the last 7 years, with Dec 2024 value amounting to $1.3 million.

  • ADC Therapeutics' Depreciation and Depletion rose 104.27% to $335,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 11.98%. This contributed to the annual value of $1.3 million for FY2024, which is 12.38% up from last year.
  • Per ADC Therapeutics' latest filing, its Depreciation and Depletion stood at $1.3 million for FY2024, which was up 12.38% from $1.2 million recorded in FY2023.
  • In the past 5 years, ADC Therapeutics' Depreciation and Depletion registered a high of $1.3 million during FY2024, and its lowest value of $774,000 during FY2020.
  • Its 3-year average for Depreciation and Depletion is $1.2 million, with a median of $1.2 million in 2023.
  • Data for ADC Therapeutics' Depreciation and Depletion shows a peak YoY spiked of 40.22% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows ADC Therapeutics' Depreciation and Depletion stood at $774,000 in 2020, then climbed by 18.86% to $920,000 in 2021, then climbed by 15.22% to $1.1 million in 2022, then rose by 11.98% to $1.2 million in 2023, then climbed by 12.38% to $1.3 million in 2024.